EpiEndo Pharmaceuticals

Reykjavik, Iceland · Founded 2014 · $11.4M raised

Headquarters
Reykjavik
Founded
2014
Business Model
B2B
Total Funding
$11.4M
Last Round
$10.5M Convertible NoteDec 2025
Rounds
2

About

EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing oral drugs for chronic respiratory diseases, with a focus on the high unmet need of COPD patients. Its lead compound, glasmacinal (formerly EP395), is a non-antibiotic macrolide designed to retain the anti-inflammatory and host-defense benefits of azithromycin without promoting antimicrobial resistance. A semi-virtual company headquartered in Iceland, EpiEndo has staff across Iceland, Sweden, Denmark, and the UK.

Summary

EpiEndo Pharmaceuticals is a Biotech company based in Reykjavik, Iceland, founded in 2014. It has raised $11.4M in total across 2 rounds, most recently a $10.5M Convertible Note round in Dec 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

ConvertibleConvertible BondDec 2025
$10.5M

Sign up to see all 2 rounds

Venture Round through Convertible Note — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EpiEndo Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/epiendo-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/epiendo-pharmaceuticals" alt="EpiEndo Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>